AA | Serum amyloid A protein | Reactive systemic amyloidosis associated with hereditary or acquired chronic inflammatory disease
|
AL | Monoclonal immunoglobulin light chains; | |
| Produced systemically | Systemic amyloidosis associated with monoclonal gammopathy, myeloma, etc. |
Produced locally | Amyloidosis localised to the urogenital tract, skin, eyes, respiratory tract, etc. |
ATTR | Normal plasma transthyretin | Senile systemic amyloidosis with prominent cardiac involvement |
Genetically variant transthyretin | Autosomal dominant hereditary amyloidosis; familial amyloid polyneuropathy, often with significant cardiac and/or renal amyloidosis |
Aβ2M | β2-microglobulin | Systemic amyloidosis with predominant periarticular involvement associated with renal failure and long term dialysis |
Aβ | (β-)amyloid precursor protein | Cerebrovascular and intracerebral plaque amyloid associated with Alzheimer’s disease |
AIAPP | Islet amyloid polypeptide | Amyloid in islets of Langerhans in type II diabetes mellitus |